• We The Patients Fly-In
  • Events Calendar
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Partners and Coalitions
    • Corporate Membership
    • Corporate Members
    • Financials
  • Issues
    • Terry’s Hot Take
    • News and Insights
    • Positions
    • Policy Supported
  • Take Action
  • Donate

Access

Season 3 | Episode 14: The Real Costs of Diabetes + Alzheimer’s

Season 3 | Episode 14: The Real Costs of Diabetes + Alzheimer’s

Apr 9, 2022 | Access, Featured

On this episode of the podcast, Terry and Bob discuss the access and affordability challenges that patients with Alzheimer’s and diabetes face. They highlight a new analysis that concludes an enormous $350 billion of prescription drug rebates were spent last...
Read more
Terry Wilcox Statement on CMS’ Coverage Determination for Alzheimer’s

Terry Wilcox Statement on CMS’ Coverage Determination for Alzheimer’s

Apr 9, 2022 | Access, Featured

WASHINGTON — Patients Rising Now Executive Director Terry Wilcox today released the following statement in response to CMS’ final decision to restrict access to FDA-approved Alzheimer’s treatments to clinical trial participants: “It’s a sad day for the millions...
Read more
Patients Rising Now: Our Most Popular Conversations and Articles in 2021

Patients Rising Now: Our Most Popular Conversations and Articles in 2021

Dec 30, 2021 | Access, Featured

In its second season, Patients Rising’s podcast has witnessed tremendous growth as we continue our coverage of topics that affect affordability and access to treatments and services, and dive into policy matters that regulate access and affordability. Here are a few...
Read more
Identifying and Limiting Low-Value Care: A Benefit Design Conundrum

Identifying and Limiting Low-Value Care: A Benefit Design Conundrum

Dec 10, 2021 | Access, Featured, Value Based Insurance Design

By Surabhi Dangi-Garimella, PhD Can health care services have low value? Turns out, they do! A service or a treatment that provides no or little benefit to the patient—or worse, might harm the patient—is a low-value service. While we might quickly jump to conclusions...
Read more
Coverage for Preventive Care Is a High-Value Insurance Design

Coverage for Preventive Care Is a High-Value Insurance Design

Oct 21, 2021 | Access, Health Insurance, Value Based Insurance Design

By Surabhi Dangi-Garimella, Ph.D. For more than a decade now, health plans have been modeling their benefit structure to encourage enrollees to use certain “high-value” services—whose clinical benefits supersede the cost—and discourage the use of “low value” services,...
Read more
S2 | E40: Congress + the Debate Right Now Over the Cures of Tomorrow

S2 | E40: Congress + the Debate Right Now Over the Cures of Tomorrow

Oct 11, 2021 | Access, Featured, Podcast

On this episode of the podcast, Terry and Bob discuss the latest on Congressional Democrats’ reconciliation bill, currently being debated, and explain provisions that will directly affect patients’ access to medications. Take the inclusion of H.R. 3, for...
Read more
« Older Entries

Categories

  • Access
  • Actions
  • California
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Terry's Hot Take
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA H.R.3 Healthcare Inequities Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden Lupus medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • Can Mark Cuban Deliver Cheaper RX? – Season 3 | Episode 20
  • What is the Future of Co-pay Accumulator and Maximizer Programs? 
  • Have Health Plans Abandoned Rare Disease Patients?: Season 3 | Episode 19
  • Patients Rising Now Pens Letter Regarding S.2910: The Expanding Access to Low-Cost Generics Act of 2021
  • OIG Report Tags Biosimilars for Medicare and Beneficiary Savings

Sign up for updates

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Facebook
  • Twitter
  • Instagram
All rights reserved. © 2022 Patients Rising Now